TICKVALE
>⌘K
Nasdaq · CIK 0001802768 · PHARMACEUTICAL PREPARATIONS

Royalty Pharma plc

RPRX chart by TradingView
P/E 38.5xP/B 3.2xP/SALES 12.3xEV/EBITDA 26.0xFCF YIELD

PRICE HISTORY

LIVE · NASDAQ
RPRX chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$2.4B
EBITDA
$1.6B
FREE CASH FLOW
EPS
$1.37
GROSS MARGIN
ROIC
4.27%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 28 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

38.5x
+140%
LATEST · Q2 FY26
38.5xQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
12.8x560.3x

P / SALES (TTM)

12.3x
+39%
LATEST · Q2 FY26
12.3xQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
6.7x12.3x

P / BOOK

3.2x
+74%
LATEST · Q2 FY26
3.2xQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
1.5x3.2x

EV / EBITDA (TTM)

26.0x
+108%
LATEST · Q2 FY26
26.0xQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
10.8x94.0x

EV / REVENUE (TTM)

15.5x
+45%
LATEST · Q2 FY26
15.5xQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
9.3x15.5x

FCF YIELD (TTM)

LATEST · Q2 FY26
Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

DIVIDEND YIELD (TTM)

LATEST · Q2 FY26
Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$0.7B
+47%
LATEST · Q2 FY26
0.7BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

EBITDA (DERIVED)

$0.1B
-60%
LATEST · Q2 FY26
0.1BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

NET INCOME

$0.0B
-88%
LATEST · Q2 FY26
0.0BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

EPS (DILUTED)

$0.03
-97%
LATEST · Q2 FY26
0.03Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

REVENUE GROWTH YOY

16.50%
+2.1pp
LATEST · Q2 FY26
16.50%Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
-16.96%21.69%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

LATEST · Q2 FY26
Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

RETURN ON CAPITAL

4.53%
-3.8pp
LATEST · Q2 FY26
4.53%Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
0.29%8.63%

RETURN ON EQUITY (TTM)

8.30%
-3.1pp
LATEST · Q2 FY26
8.30%Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
0.45%12.38%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN
OPERATING MARGIN19.75%
NET MARGIN2.65%
FCF MARGIN
156.1990.3224.46-41.40-107.27OPERNETQ1 FY19Q2 FY20Q1 FY21Q4 FY21Q3 FY22Q2 FY23Q1 FY24Q4 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

LATEST · Q2 FY26
Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

STOCK-BASED COMP

$0.1B
+$0.1B
LATEST · Q2 FY26
0.1BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

CAPITAL EXPENDITURE

LATEST · Q2 FY26
Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

SHARES OUTSTANDING

0.56B
+57%
LATEST · Q2 FY26
0.56BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

DIVIDEND / SHARE

LATEST · Q2 FY26
Q1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$0.8B
-67%
LATEST · Q2 FY26
0.8BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

TOTAL DEBT

$9.0B
+52%
LATEST · Q2 FY26
9.0BQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26

DEBT / EBITDA (TTM)

5.9x
+65%
LATEST · Q2 FY26
5.9xQ1 FY19Q1 FY21Q3 FY22Q1 FY24Q2 FY26
3.2x22.8x

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 85.63%INSIDERS 6.48%OTHER / RETAIL 7.89%962 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Morgan Stanley9.79%43.6M$2.47B-21.2%
Capital International Investors7.86%35.0M$1.99B+12.5%
Blackrock Inc.5.82%25.9M$1.47B-1.1%
FMR, LLC5.65%25.2M$1.43B-4.3%
State Street Corporation2.47%11.0M$623.9M+3.2%
Swedbank AB2.41%10.7M$608.9M-7.4%
BAILLIE GIFFORD & CO2.25%10.0M$568.6M-38.0%
Capital World Investors1.80%8.0M$456.2MNEW
Geode Capital Management, LLC1.77%7.9M$446.8M+1.9%
Adage Capital Partners GP L.L.C.1.68%7.5M$424.7M-36.3%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.